全球结构性心臟阻塞设备市场：市场规模、份额、趋势分析（按类型、最终用途和地区）、细分市场预测（2025-2030 年）

市场规模与趋势：

预计 2024 年全球结构性心臟阻塞设备市场规模将达到 40 亿美元，2025 年至 2030 年的复合年增长率将达到 7.0%。

结构性心臟阻塞设备市场受到结构性心臟病负担日益加重、微创疗法日益普及以及监管和报销政策利好变化的驱动。临床认知度的提升和手术流程的创新正在扩大患者群体，增强了强劲增长的前景。

结构性心臟病盛行率的上升是结构性心臟阻塞设备市场的主要驱动力。随着诊断技术的不断进步，心房中膈缺损症、卵圆孔未闭合和左心耳畸形等疾病正日益受到临床关注。美国心臟协会2024年统计数据更新预测，美国心房颤动(AF)的盛行率将从2010年的约520万增至2030年的1210万，凸显了临床对有效干预措施日益增长的需求。随着认知度的提高和诊断途径的标准化，适合接受封堵治疗的患者群体将显着扩大，为市场成长奠定坚实的基础。

随着全球心房颤动 (AF) 盛行率持续上升，左心耳封堵器 (LAAO) 在结构性心臟阻塞设备市场中日益受到青睐。 LAAO 为非瓣膜性心房颤动患者（尤其是高出血风险患者）提供了一种非药物性的口服抗凝血剂替代疗法，用于预防中风。 2025 年 2 月发表于《欧洲心臟杂誌增刊》的一篇论文强调，对于长期口服抗凝血治疗 (OAT) 禁忌的患者，LAAO 的应用日益广泛。该论文强调，儘管 OAT 在预防中风方面发挥重要作用，但某些患者，尤其是有出血事件病史的患者，仍面临较高的缺血性中风风险。

监管和报销倡议在塑造结构性心臟阻塞设备市场方面发挥日益重要的作用。良好的政策环境对于鼓励临床应用、刺激创新投资以及扩大患者获得先进疗法的管道至关重要。 2025年3月，美国医疗保险和医疗补助服务中心 (CMS)核准了REDUCE-AF 临床试验，该试验旨在评估 LAmbre Plus 左心耳封堵器在实证覆盖 (CED) 框架下的疗效。该决定体现了监管机构持续致力于建立强有力的临床证据，以支持该装置在非瓣膜性心房颤动患者中的应用。

目录

第一章 分析方法与范围

第二章执行摘要

3. 结构性心臟阻塞设备市场：驱动因素、趋势与范围

• 市场联动展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制分析
• 结构性心臟阻塞设备市场：分析工具
  • 产业分析：波特五力分析
  • PESTEL分析

第四章。结构性心臟阻塞设备市场：按类型估计和趋势分析

• 结构性心臟阻塞设备市场：按类型分類的仪表板
• 结构性心臟阻塞设备市场：按类型进行的变化分析
• 结构性心臟阻塞设备市场：市场规模预测与趋势分析（按类型）（2018-2030 年）
• 左心耳（LAA）阻塞设备
• 心房中隔缺损 (ASD)阻塞设备
• 开放性动脉导管闭（PDA）阻塞设备
• 其他的

5. 结构性心臟阻塞设备市场：依最终用途的估计和趋势分析

• 结构性心臟阻塞设备市场：依最终用途分類的仪表板
• 结构性心臟阻塞设备市场：依最终用途进行的变化分析
• 结构性心臟阻塞设备市场：按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
• 医院
• 专科诊所
• 学术研究所

6. 结构性心臟阻塞设备市场：区域估计和趋势分析（按国家、类型、适应症和最终用途）

• 全球结构性心臟阻塞设备市场：按地区划分
• 市场规模预测及趋势分析（2018-2030年）
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 瑞典
  • 挪威
  • 丹麦
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 泰国
  • 韩国
• 拉丁美洲
  • 巴西
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿拉伯聯合大公国
  • 科威特

第七章 竞争态势

• 近期趋势和影响分析：按主要製造商
• 公司/竞争对手分类
• 主要企业市场占有率分析（2024年）
  • 雅培
  • 波士顿科学公司
  • 奥库泰克
  • 先健科技
  • Medtronic
  • 戈尔公司
  • 瑞普医疗科技（北京）有限公司
  • M Tree Medical（Cardia 株式会社）
  • Biosense Webster（强生公司）
  • PFM医疗

Market Size & Trends:

The global structural heart occlusion devices market size was estimated at USD 4.0 billion in 2024 and is projected to grow at a CAGR of 7.0% from 2025 to 2030. The structural heart occlusion devices market is advancing due to the rising burden of structural heart diseases, increasing acceptance of minimally invasive therapies, and favorable regulatory and reimbursement changes. Growing clinical awareness and procedural innovations are expanding the eligible patient pool, reinforcing a strong positive growth outlook.

The increasing prevalence of structural heart diseases is a major driver for the structural heart occlusion devices market. Conditions such as atrial septal defects, patent foramen ovale, and left atrial appendage abnormalities are gaining greater clinical attention as diagnostic technologies continue to advance. The American Heart Association's 2024 Statistical Update projects that the prevalence of atrial fibrillation (AF) in the U.S. will rise from approximately 5.2 million in 2010 to 12.1 million by 2030, underscoring the growing clinical need for effective interventions. As awareness improves and diagnostic pathways become more standardized, the addressable patient population for occlusion therapies is expanding significantly, creating a strong foundation for market growth.

As the prevalence of atrial fibrillation (AF) continues to rise globally, Left Atrial Appendage Occlusion (LAAO) procedures are gaining traction within the Structural Heart Occlusion Devices market. LAAO offers a non-pharmacologic alternative to oral anticoagulants for stroke prevention in patients with non-valvular AF, particularly those at high bleeding risk. A February 2025 article published in the European Heart Journal Supplements focused on the growing adoption of LAAO for patients with contraindications to long-term oral anticoagulant therapy (OAT). The article emphasizes that despite OAT's role in stroke prevention, certain patients, especially those with a history of bleeding events, remain at high risk for ischemic strokes.

Regulatory and reimbursement initiatives are playing an increasingly important role in shaping the structural heart occlusion devices market. Favorable policy environments are essential to encourage clinical adoption, promote investment in innovation, and expand patient access to advanced therapies. In March 2025, the Centers for Medicare & Medicaid Services (CMS) approved the REDUCE-AF clinical trial under Coverage with Evidence Development (CED) to evaluate the LAmbre Plus Left Atrial Appendage Closure System. This decision reflects continued regulatory emphasis on building robust clinical evidence to support device utilization in patients with non-valvular atrial fibrillation.

Global Structural Heart Occlusion Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global structural heart occlusion devices market report based on type, end-use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Left Atrial Appendage (LAA) Occlusion Devices
• Atrial Septal Defect (ASD) Occluders
• Patent Ductus Arteriosus (PDA) Occlusion Devices
• Others
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Specialty clinics
• Academic and Research Institutes
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Segment
  • 2.2.2. End Use Segment
  • 2.2.3. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Global Structural Heart Occlusion Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of structural heart diseases
    • 3.2.1.2. Growth of minimally invasive cardiac interventions
    • 3.2.1.3. Regulatory and reimbursement tailwinds
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Regulatory approval delays
• 3.3. Structural Heart Occlusion Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Structural Heart Occlusion Devices Market: Type Estimates & Trend Analysis

• 4.1. Structural Heart Occlusion Devices Market: Type Dashboard
• 4.2. Structural Heart Occlusion Devices Market: Type Movement Analysis
• 4.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Left Atrial Appendage (LAA) Occlusion Devices
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Atrial Septal Defect (ASD) Occluders
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Patent Ductus Arteriosus (PDA) Occlusion Devices
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Structural Heart Occlusion Devices Market: End Use Estimates & Trend Analysis

• 5.1. Structural Heart Occlusion Devices Market: End Use Dashboard
• 5.2. Structural Heart Occlusion Devices Market: End Use Movement Analysis
• 5.3. Structural Heart Occlusion Devices Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Specialty Clinics
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Academic and Research Institutes
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Structural Heart Occlusion Devices Market: Regional Estimates & Trend Analysis by Country, Type, Indication, & End Use

• 6.1. Global Structural Heart Occlusion Devices Market: Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Regulatory framework/ reimbursement structure
    • 6.3.4.3. Competitive scenario
    • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3. Japan
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.7. South Korea
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.3. South Africa
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2024
  • 7.3.1. Abbott
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Boston Scientific Corporation
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Occlutech
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Lifetech Scientific
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Medtronic
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. W. L. Gore & Associates
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Lepu Medical Technology (Beijing)Co.,Ltd
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Emtree Medical (Cardia Inc.)
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Biosense Webster (Johnson & Johnson)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. PFM Medical GMBH
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Global structural heart occlusion devices market, by type 2018 - 2030 (USD Million)
• Table 4 Global structural heart occlusion devices market, by end use, 2018 - 2030
• Table 5 Global structural heart occlusion devices market, by region, 2018 - 2030 (USD Million)
• Table 6 North America structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
• Table 7 North America structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 8 North America structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 9 U.S structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 10 U.S structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 11 Canada structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 12 Canada structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 13 Mexico structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 14 Mexico structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 15 Europe structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
• Table 16 Europe structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 17 Europe structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 18 UK structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 19 UK structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 20 Germany structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 21 Germany structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 22 France structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 23 France structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 24 Italy structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 25 Italy structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 26 Spain structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 27 Spain structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 28 Denmark structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 29 Denmark structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 30 Sweden structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 31 Sweden structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 32 Norway structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 33 Norway structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 36 Asia Pacific structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 37 Japan structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 38 Japan structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 39 China structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 40 China structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 41 India structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 42 India structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 43 Australia structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
• Table 44 Australia structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 45 Australia structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 46 Thailand structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 47 Thailand structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 48 South Korea structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 49 South Korea structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 50 Latin America structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
• Table 51 Latin America structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 52 Latin America structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 53 Brazil structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 54 Brazil structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 55 Argentina structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 56 Argentina structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 57 MEA structural heart occlusion devices market, by country, 2018 - 2030 (USD Million)
• Table 58 MEA structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 59 MEA structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 60 South Africa structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 61 South Africa structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 62 Saudi Arabia structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 63 Saudi Arabia structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 64 UAE structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 65 UAE structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 66 Kuwait structural heart occlusion devices market, by type, 2018 - 2030 (USD Million)
• Table 67 Kuwait structural heart occlusion devices market, by end use, 2018 - 2030 (USD Million)
• Table 68 Participant's overview
• Table 69 Financial performance
• Table 70 Key companies undergoing expansions
• Table 71 Key companies undergoing acquisitions
• Table 72 Key companies undergoing collaborations
• Table 73 Key companies launching new products
• Table 74 Key companies undergoing partnerships
• Table 75 Key companies undertaking other strategies

List of Figures

• Fig. 1 Structural heart occlusion devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Structural heart occlusion devices market revenues, 2024 (USD Millions)
• Fig. 9 Market driver relevance analysis (Current & future impact)
• Fig. 10 Market restraint relevance analysis (Current & future impact)
• Fig. 11 Porter's five forces analysis
• Fig. 12 PESTLE analysis
• Fig. 13 Structural heart occlusion devices market Type outlook:
• Fig. 14 Structural heart occlusion devices market: Type movement analysis
• Fig. 15 Segment dashboard
• Fig. 16 Global left atrial appendage (LAA) occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 17 Global atrial septal defect (ASD) occluders market, 2018 - 2030 (USD Million)
• Fig. 18 Global patent ductus arteriosus (PDA) occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 19 Global others market, 2018 - 2030 (USD Million)
• Fig. 20 Structural heart occlusion devices market end use outlook:
• Fig. 21 Structural heart occlusion devices market: end use movement analysis
• Fig. 22 Global hospitals market, 2018 - 2030 (USD Million)
• Fig. 23 Global specialty clinics market, 2018 - 2030 (USD Million)
• Fig. 24 Global academic and research institutes market, 2018 - 2030 (USD Million)
• Fig. 25 Regional market place: Key takeaways
• Fig. 26 North America structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 27 U.S structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 28 Canada structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 29 Mexico structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 30 Europe structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 31 Germany structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 32 UK structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 33 France structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 34 Italy structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 35 Spain structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 36 Sweden structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 37 Denmark structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 38 Norway structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 39 Asia Pacific structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 40 Japan structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 41 China structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 42 India structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 43 Australia structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 44 Thailand structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 45 South Korea structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 46 Latin America structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 47 Brazil structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 48 Argentina structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 49 MEA structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 50 South Africa structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 51 Saudi Arabia structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 52 UAE structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 53 Kuwait structural heart occlusion devices market, 2018 - 2030 (USD Million)
• Fig. 54 Market Participant Categorization
• Fig. 55 Strategy mapping